FilingSEC EDGAR6-K
Optimi Health Announces Phase 3 Clinical Trial for MDMA-Assisted Therapy in PTSD
· SEC accepted
StagePhase 3
Filing content
The company plans to initiate a Health Canada-authorized Phase 3 clinical trial evaluating MDMA-assisted therapy in up to 100 patients, with the trial expected to begin in 2027.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…